Related Experiment Video
Updated: Jul 16, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Recent Advances in Medium-Chain Triglycerides in Chronic Disease Prevention
Yonghui Yu1,2, Wanxin Ya2, Jingjie Zhang1,2
1Key Laboratory of Geriatric Nutrition and Health, Ministry of Education, Beijing Technology and Business University, Beijing 100048, China.
Nutrients
|July 15, 2026
Summary
Medium-chain triglycerides (MCTs) offer therapeutic potential for metabolic, neurological, gut, and muscle health. Research highlights their role in disease management and performance enhancement, warranting further clinical investigation.
Area of Science:
- Nutritional Science
- Biochemistry
- Metabolic Research
Background:
- Medium-chain triglycerides (MCTs) possess unique metabolic properties.
- Growing evidence suggests MCTs play regulatory roles in chronic diseases.
Purpose of the Study:
- To systematically review MCTs' mechanisms and applications in chronic diseases.
- To explore MCTs' potential in metabolic, neurological, gut, and muscle health.
Main Methods:
- Systematic literature review of recent research on MCTs and their metabolites.
- Analysis of proposed mechanisms across various health domains.
Main Results:
- MCTs show promise for obesity, type 2 diabetes mellitus (T2DM), and liver diseases by improving insulin sensitivity and energy expenditure.
- In neurological disorders, MCTs may aid Alzheimer's disease (AD), Parkinson's disease (PD), and epilepsy via ketogenic supply and neuroprotection.
- MCTs can benefit gut health by modulating microbiota and enhancing barrier function.
- For muscle health, MCTs support energy metabolism and protein homeostasis, aiding sarcopenia and exercise performance.
Conclusions:
- MCTs present broad therapeutic prospects in precision nutrition and disease management.
- Further rigorous clinical trials are essential to validate MCTs' efficacy and safety.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:06Fats as Energy Storage Molecules
Triglycerides are a form of long-term energy storage molecules. They are made of glycerol and three fatty acids. To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis, takes place in the cytoplasm. The resulting fatty acids are oxidized by β-oxidation into acetyl-CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis directly...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:24Lipid Absorption
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...